Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-17

Clinical Trial Update: ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria [Phase 4]

View source ↗

Summary

Phase 4 trial update indicating completion of the ADDM study evaluating Amtrel (amlodipine) and Co-Diovan (losartan/hydrochlorothiazide) in patients with type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amtrel (amlodipine)
  • Co-Diovan (losartan/hydrochlorothiazide)

Snippet

Sponsor: TSH Biopharm Corporation Limited | Conditions: Hypertension, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED